Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jul 17 12:46PM ET
2.99
Dollar change
-0.10
Percentage change
-3.24
%
Index- P/E- EPS (ttm)-3.19 Insider Own13.69% Shs Outstand21.61M Perf Week-2.29%
Market Cap64.61M Forward P/E- EPS next Y-1.37 Insider Trans-2.46% Shs Float18.66M Perf Month-7.14%
Income-18.07M PEG- EPS next Q-0.23 Inst Own11.97% Short Float1.46% Perf Quarter-44.11%
Sales0.00M P/S- EPS this Y60.35% Inst Trans-2.74% Short Ratio2.28 Perf Half Y-33.41%
Book/sh2.66 P/B1.13 EPS next Y-1.26% ROA-31.05% Short Interest0.27M Perf Year52.55%
Cash/sh0.56 P/C5.35 EPS next 5Y2.10% ROE-34.21% 52W Range1.01 - 7.42 Perf YTD-1.92%
Dividend Est.- P/FCF- EPS past 5Y39.67% ROI-19.78% 52W High-59.70% Beta2.23
Dividend TTM- Quick Ratio2.82 Sales past 5Y0.00% Gross Margin- 52W Low196.04% ATR (14)0.25
Dividend Ex-Date- Current Ratio2.82 EPS Y/Y TTM38.81% Oper. Margin0.00% RSI (14)44.14 Volatility8.75% 8.76%
Employees15 Debt/Eq0.00 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price13.00
Option/ShortNo / Yes LT Debt/Eq0.00 EPS Q/Q18.59% Payout- Rel Volume0.07 Prev Close3.09
Sales Surprise- EPS Surprise-514.29% Sales Q/Q- EarningsMay 15 AMC Avg Volume119.93K Price2.99
SMA20-0.50% SMA50-9.76% SMA200-15.75% Trades Volume4,213 Change-3.24%
Date Action Analyst Rating Change Price Target Change
Jul-24-17Initiated William Blair Outperform
Jul-24-17Initiated Jefferies Buy $20
Jul-24-17Initiated BofA/Merrill Buy $19
Jul-01-24 08:00AM
May-15-24 10:53PM
05:13PM
May-07-24 09:35AM
May-06-24 04:05PM
04:33PM Loading…
May-03-24 04:33PM
04:05PM
May-02-24 07:24AM
May-01-24 08:45AM
08:30AM
Apr-16-24 09:52AM
Apr-15-24 05:20PM
Mar-12-24 08:00AM
Feb-15-24 04:05PM
Feb-01-24 04:30PM
12:30PM Loading…
Oct-31-23 12:30PM
Apr-04-23 09:55AM
Mar-14-23 09:55AM
Feb-22-23 11:49AM
Feb-21-23 02:50PM
08:30AM
Dec-29-22 12:00PM
Nov-30-22 07:00AM
Nov-24-22 09:55AM
Nov-10-22 08:00AM
Nov-04-22 12:00PM
Nov-01-22 08:15AM
Oct-26-22 06:05AM
Sep-30-22 08:41AM
Sep-22-22 08:00AM
07:00AM Loading…
Sep-06-22 07:00AM
Aug-15-22 04:15PM
Aug-01-22 07:51AM
Jul-08-22 08:31AM
Jun-29-22 09:46AM
06:30AM
May-19-22 07:00AM
06:40AM
May-17-22 07:00AM
May-13-22 07:00AM
May-11-22 07:57AM
May-10-22 12:43PM
May-05-22 04:15PM
Apr-21-22 09:40AM
08:00AM
Apr-05-22 09:40AM
Mar-28-22 04:20PM
Mar-22-22 08:04AM
Jan-27-22 01:38PM
Jan-05-22 08:04AM
Jan-04-22 08:45AM
07:00AM
Dec-30-21 04:32AM
Dec-20-21 10:56AM
Nov-12-21 07:50AM
Oct-07-21 09:22AM
Sep-30-21 04:30PM
Sep-16-21 02:33PM
08:15AM
Sep-10-21 08:30AM
Sep-07-21 04:05PM
Aug-27-21 09:48AM
07:45AM
Aug-11-21 04:20PM
Jul-08-21 08:15AM
Jul-01-21 01:39PM
08:00AM
Jun-30-21 09:33AM
Jun-24-21 07:00AM
May-19-21 07:00AM
May-11-21 04:18PM
Mar-24-21 04:36PM
Mar-04-21 08:30AM
Mar-02-21 07:00AM
Jan-11-21 06:30AM
Jan-06-21 09:30AM
Dec-23-20 03:41AM
Dec-21-20 08:00AM
Dec-14-20 08:32AM
Dec-01-20 10:12AM
Nov-29-20 08:33PM
Nov-24-20 08:28AM
Nov-19-20 10:02AM
Nov-12-20 07:03PM
Oct-24-20 04:35AM
Oct-20-20 09:24AM
Oct-13-20 08:30AM
Oct-12-20 07:00AM
Sep-21-20 06:07PM
Sep-10-20 08:45AM
Aug-25-20 01:25PM
Aug-05-20 04:10PM
Aug-04-20 03:31PM
Aug-03-20 08:10AM
08:00AM
Jun-29-20 08:30AM
Jun-12-20 11:42AM
Jun-10-20 09:54AM
Jun-04-20 09:15AM
Jun-03-20 04:01PM
Aileron Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of a novel class of therapeutics for the treatment of cancer and other diseases. It focuses on its lead product candidate, ALRN-6924, which is a cell-permeating peptide that disrupts the interaction of p53 suppressors MDM2 and MDMX with tumor suppressor p53 to reactivate tumor suppression in non-mutant, or wild-type, p53 cancers. The company was founded by Gregory L. Verdine, Rosana Kapeller, Huw M. Nash, Joseph A. Yanchik III, and Loren David Walensky on August 6, 2001 and is headquartered in Austin, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
UNIVERSITY OF TEXAS/TEXAS AM I10% OwnerJun 17 '24Sale3.254,70715,2981,746,549Jun 17 07:03 PM
UNIVERSITY OF TEXAS/TEXAS AM I10% OwnerJun 14 '24Sale3.301,9006,2701,751,256Jun 17 07:03 PM
UNIVERSITY OF TEXAS/TEXAS AM I10% OwnerJun 12 '24Sale3.259,34230,3621,753,156Jun 12 06:18 PM
UNIVERSITY OF TEXAS/TEXAS AM I10% OwnerJun 11 '24Sale3.265,75218,7441,762,498Jun 12 06:18 PM
UNIVERSITY OF TEXAS/TEXAS AM I10% OwnerJun 10 '24Sale3.309,57731,6041,768,250Jun 12 06:18 PM
UNIVERSITY OF TEXAS/TEXAS AM I10% OwnerJun 07 '24Sale3.261,7405,6641,777,827Jun 07 06:59 PM
UNIVERSITY OF TEXAS/TEXAS AM I10% OwnerJun 06 '24Sale3.294,28414,1041,779,567Jun 07 06:59 PM
UNIVERSITY OF TEXAS/TEXAS AM I10% OwnerJun 05 '24Sale3.306,29120,7601,783,851Jun 07 06:59 PM
UNIVERSITY OF TEXAS/TEXAS AM I10% OwnerMay 01 '24Sale4.2120,31585,4731,779,306May 01 07:15 PM
UNIVERSITY OF TEXAS/TEXAS AM I10% OwnerApr 30 '24Sale4.97904481,799,621May 01 07:15 PM
UNIVERSITY OF TEXAS/TEXAS AM I10% OwnerApr 29 '24Sale4.9510,74653,1821,799,711May 01 07:15 PM
WINDSOR JAMES BRIANPresident and COODec 15 '23Buy3.37225758225Dec 18 05:56 PM
WINDSOR JAMES BRIANPresident and COONov 20 '23Buy1.975,0769,9875,122Nov 21 04:43 PM